Clover Health Investments Statistics
Total Valuation
CLOV has a market cap or net worth of $2.84 billion. The enterprise value is $2.68 billion.
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLOV has 526.68 million shares outstanding. The number of shares has increased by 5.19% in one year.
| Current Share Class | 430.97M |
| Shares Outstanding | 526.68M |
| Shares Change (YoY) | +5.19% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 21.72% |
| Owned by Institutions (%) | 24.49% |
| Float | 408.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 54.66 |
| PS Ratio | 1.29 |
| Forward PS | 0.94 |
| PB Ratio | 8.37 |
| P/TBV Ratio | 8.47 |
| P/FCF Ratio | 52.24 |
| P/OCF Ratio | 49.77 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 49.06 |
Financial Position
The company has a current ratio of 1.33
| Current Ratio | 1.33 |
| Quick Ratio | 1.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.86% and return on invested capital (ROIC) is -10.53%.
| Return on Equity (ROE) | -16.86% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -10.53% |
| Return on Capital Employed (ROCE) | -15.76% |
| Weighted Average Cost of Capital (WACC) | 17.91% |
| Revenue Per Employee | $3.05M |
| Profits Per Employee | -$78,648 |
| Employee Count | 724 |
| Asset Turnover | 3.45 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.09% in the last 52 weeks. The beta is 2.48, so CLOV's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | +101.09% |
| 50-Day Moving Average | 3.68 |
| 200-Day Moving Average | 2.78 |
| Relative Strength Index (RSI) | 77.63 |
| Average Volume (20 Days) | 8,860,813 |
Short Selling Information
The latest short interest is 24.85 million, so 4.72% of the outstanding shares have been sold short.
| Short Interest | 24.85M |
| Short Previous Month | 28.60M |
| Short % of Shares Out | 4.72% |
| Short % of Float | 6.08% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, CLOV had revenue of $2.21 billion and -$56.94 million in losses. Loss per share was -$0.11.
| Revenue | 2.21B |
| Gross Profit | 405.75M |
| Operating Income | -56.92M |
| Pretax Income | -56.94M |
| Net Income | -56.94M |
| EBITDA | -56.69M |
| EBIT | -56.92M |
| Loss Per Share | -$0.11 |
Full Income StatementBalance Sheet
The company has $203.54 million in cash and n/a in debt, giving a net cash position of $173.27 million or $0.33 per share.
| Cash & Cash Equivalents | 203.54M |
| Total Debt | n/a |
| Net Cash | 173.27M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 339.43M |
| Book Value Per Share | 0.65 |
| Working Capital | 111.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $57.25 million and capital expenditures -$2.71 million, giving a free cash flow of $54.54 million.
| Operating Cash Flow | 57.25M |
| Capital Expenditures | -2.71M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 54.54M |
| FCF Per Share | $0.10 |
Full Cash Flow StatementMargins
Gross margin is 18.36%, with operating and profit margins of -2.58% and -2.58%.
| Gross Margin | 18.36% |
| Operating Margin | -2.58% |
| Pretax Margin | -2.58% |
| Profit Margin | -2.58% |
| EBITDA Margin | -2.56% |
| EBIT Margin | -2.58% |
| FCF Margin | 2.47% |